Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF EBIT

The latest EBIT for CDC is $-4.7M as of June 2026. That compares with $-7.7M in the prior-year period — up 40.0% year over year. That is above the sector sector average of $-63M. Investors often review this figure alongside Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, CDC's EBIT moved from $-7.7M to $-4.7M — a 40.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF's operating scale or balance-sheet position.

Against its sector companies, CDC currently prints $-4.7M for EBIT, while the sector average sits near $-63M. That is roughly 92.6% above the sector mean. Large gaps often invite a closer look at Victory Portfolios II - VictoryShares US EQ Income Enhanced Volatility Wtd ETF's growth, margins, and balance sheet.

A EBIT figure of $-4.7M for CDC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.

After noting CDC's EBIT ($-4.7M), review year-over-year change from $-7.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.